Tech Company Financing Transactions
CardioOptics Funding Round
CardioOptics secured a $26.5 million Series B investment round on 3/8/2006. Investors included Novo Ventures, Cardinal Venture Capital and Hillman Company.
Transaction Overview
Company Name
Announced On
3/8/2006
Transaction Type
Venture Equity
Amount
$26,500,000
Round
Series B
Investors
Novo Ventures (Lead Investor) (Jack Nielson)
Investor Growth Capital (Stephen Campe)
Proceeds Purpose
Proceeds will be used primarily to commercialize CardioOptics' first product, the FDA-approved Coronary Sinus Access system designed for vision-guided implantation of pacemakers to treat heart failure.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
2425 55th St. 100
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Overview
The company's proprietary infrared fiber-optic Trans-Blood Vision technology, a unique therapeutic catheter system designed to allow doctors to see directly through flowing blood and inside the heart as they treat cardiovascular disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Todd Davenport
Controller
Dana Kelly
Vice President
David Amundson
VP - Manufacturing
Jeffrey Castleberry
VP - R & D
John Hanlin
Browse more venture capital transactions:
Prev: 3/8/2006: Carbonite venture capital transaction
Next: 3/8/2006: Amedica venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to record every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs